The acquisition of Varian by Agilent has cleared a key milestone, according to Agilent president and CEO Bill Sullivan. The companies have been granted conditional antitrust clearance from the European Commission for the deal.
The acquisition of Varian by Agilent has cleared a key milestone, according to Agilent president and CEO Bill Sullivan. The companies have been granted conditional antitrust clearance from the European Commission for the deal.
Under the conditions of the decision the companies have committed to sell Varian's laboratory gas chromatography business, triple quadrupole gas chromatography-mass spectrometry business and inductively coupled plasma-mass spectrometry business, as well as Agilent's micro gas chromatography business.
According to a statement this process has been initiated and the companies have started to engage with a number of interested purchasers. The aggregate fiscal 2009 revenues of these four businesses were under $100 million.
“We are pleased to have received conditional clearance from the Commission”, said Bill Sullivan. “We are committed to ensuring that each of these four businesses is successfully divested as a viable, competitive business and that all customers remain fully supported during and beyond the divestiture process.
Clearance by the US Federal Trade Commission (FTC) is still pending, although the companies report that they do not expect the FTC to seek additional remedies beyond those committed to for the European Commission.
More information from the companies is available at www.agilent.com
Best of the Week: EAS Conference Coverage, IR Spectroscopy, Microplastics
November 22nd 2024Top articles published this week include highlights from the Eastern Analytical Symposium, a news article about the infrared (IR) spectroscopy market, and a couple of news articles recapping spectroscopic analysis of microplastics.
FT-IR Analysis of pH and Xylitol Driven Conformational Changes of Ovalbumin–Amide VI Band Study
November 21st 2024This study uses Fourier transform infrared (FT-IR) spectroscopy to analyze how the globular protein ovalbumin's secondary structures transition under varying pH conditions in the presence of the cosolvent xylitol, highlighting the role of noncovalent interactions in these conformational changes.